Biomarkers for diagnosis of pre-eclampsia and endometriosis

被引：3

作者：

Wahid, Braira ^{[1
,2
]}

Rafique, Shazia ^{[3
]}

Ali, Amjad ^{[2
]}

Waqar, Muhammad ^{[1
,2
]}

Nabi, Ghulam ^{[4
]}

Wasim, Muhammad ^{[5
]}

Idrees, Muhammad ^{[1
,2
,3
,5
]}

机构：

[1] Al Sudais Plaza Abdalian Cooperat Soc, Genome Ctr Mol Based Diagnost & Res, Lahore, Pakistan

[2] Univ Punjab, CAMB, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan

[3] Univ Punjab, CEMB, Div Mol Virol & Diagnost, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan

[4] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China

[5] Khyber Teaching Hosp, Dept Med, Peshawar, Pakistan

来源：

BIOMARKERS IN MEDICINE | 2018年 / 12卷 / 10期

关键词：

biomarkers; diagnosis; endometriosis; gynecological disorders; pre-eclampsia; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS MARKERS; PERITONEAL-FLUID; HYPERTENSIVE DISORDERS; POTENTIAL BIOMARKER; PROTEOMICS ANALYSIS; CIRCULATING LEVELS; SERUM MARKERS; KIDNEY INJURY; WOMEN;

D O I：

10.2217/bmm-2018-0058

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Gynecological disorders are leading public health problems in developing countries with substantial impact on women's quality of life. Significant proportion of maternal mortality and reproductive morbidity is attributed to misdiagnosis andmismanagement of pregnancy related lethal pathological conditions and affect women's health. Timely diagnosis is necessary to prevent maternal deaths and to manage complications. Biomarker development will create a wide window of opportunity for early diagnosis. This review discusses the current status of biomarkers and recent advances in 'omics' technology for early screening of endometriosis and pre-eclampsia because of significant global bioburden associated with these disorders. This review will also give baseline data for future biomarker development strategies.

引用

页码：1161 / 1173

页数：13

共 98 条

[1] SURVIVIN AND VEGF AS NOVEL BIOMARKERS IN DIAGNOSIS OF ENDOMETRIOSIS [J].